{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:25:19Z","timestamp":1774520719105,"version":"3.50.1"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Shock is a severe, life-threatening medical condition with a high mortality rate worldwide. All four major categories of shock (along with their various subtypes)\u2014hypovolemic, distributive, cardiogenic, and obstructive, involve a dramatic mismatch between oxygen supply and demand, and share standard features of decreased cardiac output, reduced blood pressure, and overall hypoperfusion. Immediate and appropriate intervention is required regardless of shock type, as a delay can result in cellular dysfunction, irreversible multiple organ failure, and death. Studies have shown that dysfunction and downregulation of adrenergic receptors (ARs) are often implicated in these shock conditions; for example, their density is shown to be decreased in hypovolemic and cardiogenic shock, while their reduced signaling in the brain and vasculature decrease blood perfusion and oxygen supply. There are two main categories of ARs, \u03b1, and \u03b2, each with its subtypes and distributions. Our group has demonstrated that a dose of .02\u00a0mg\/kg body wt of centhaquine (CQ) specifically activates \u03b12B ARs on venous circulation along with the central \u03b12A ARs after hypovolemic\/hemorrhagic shock. Activating these receptors by CQ increases cardiac output (CO) and reduces systemic vascular resistance (SVR), with a net increase in blood pressure and tissue perfusion. The clinical trials of CQ conducted by Pharmazz Inc. in India have demonstrated significantly improved survival in shock patients. CQ improved blood pressure and shock index, indicating better blood circulation, and reduced lactate levels in the blood compared to in-use standard resuscitative agents. After successful clinical trials, CQ is being marketed as a drug (Lyfaquin<jats:sup>\u00ae<\/jats:sup>) for hypovolemic\/hemorrhagic shock in India, and United States FDA has approved the phase III IND application. It is anticipated that the phase III trial in the United States will begin in 2023. Thus, we have demonstrated that \u03b12 ARs could be suitable targets for treating or managing hypovolemic\/hemorrhagic shock. Further understanding of ARs in shock would help find new potential pharmacological targets.<\/jats:p>","DOI":"10.3389\/fphys.2023.1094591","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T05:48:00Z","timestamp":1673848080000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Role of adrenergic receptors in shock"],"prefix":"10.3389","volume":"14","author":[{"suffix":"III","given":"Mathew","family":"Geevarghese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaresh K.","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1124\/mol.56.1.154","article-title":"Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice","volume":"56","author":"Altman","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1378\/chest.99.4.956","article-title":"Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock","volume":"99","author":"Bakker","year":"1991","journal-title":"Chest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00508-012-0209-y","article-title":"Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock","volume":"124","author":"Balik","year":"2012","journal-title":"Wien Klin. Wochenschr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/cphy.c110041","article-title":"Pathophysiology of acute kidney injury","volume":"2","author":"Basile","year":"2012","journal-title":"Compr. Physiol."},{"key":"B5","first-page":"1025","article-title":"The role of beta adrenergic blockade in the treatment of septic shock","volume":"130","author":"Berk","year":"1970","journal-title":"Surg. Gynecol. Obstet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ejphar.2013.05.004","article-title":"Centhaquin antinociception in mice is mediated by \u03b12A- and \u03b12B- but not \u03b12C-adrenoceptors","volume":"715","author":"Bhalla","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4103\/0974-2700.82211","article-title":"Clinical pathology of the shock syndromes","volume":"4","author":"Bonanno","year":"2011","journal-title":"J. Emerg. Trauma Shock"},{"key":"B8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4103\/0974-2700.82210","article-title":"Physiopathology of shock","volume":"4","author":"Bonanno","year":"2011","journal-title":"J. Emerg. Trauma Shock"},{"key":"B9","first-page":"281","article-title":"Vascular adrenergic interactions during hemorrhagic shock","volume":"44","author":"Bond","year":"1985","journal-title":"Fed. Proc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.biolcel.2004.03.006","article-title":"alpha2-adrenergic receptor subtypes - novel functions uncovered in gene-targeted mouse models","volume":"96","author":"Brede","year":"2004","journal-title":"Biol. Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/s0306-4522(01)00531-0","article-title":"Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice","volume":"109","author":"Bucheler","year":"2002","journal-title":"Neuroscience"},{"key":"B12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13613-021-00869-7","article-title":"The autonomic nervous system in septic shock and its role as a future therapeutic target: A narrative review","volume":"11","author":"Carrara","year":"2021","journal-title":"Ann. Intensive Care"},{"key":"B13","first-page":"955","article-title":"Differential distribution of-adrenergic receptor subtypes in blood vessels of knockout mice lacking 1-or 2-adrenergic receptors","volume-title":"Mol Pharmacol","author":"Chruscinski","year":"2001"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"B15","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3389\/fphar.2018.00904","article-title":"New insights in cardiac beta-adrenergic signaling during heart failure and aging","volume":"9","author":"de Lucia","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/cc8026","article-title":"Bench-to-bedside review: Beta-adrenergic modulation in sepsis","volume":"13","author":"de Montmollin","year":"2009","journal-title":"Crit. Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1021\/bi00384a001","article-title":"A family of receptors coupled to guanine nucleotide regulatory proteins","volume":"26","author":"Dohlman","year":"1987","journal-title":"Biochemistry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.4103\/0366-6999.185856","article-title":"Efficacy and safety of esmolol in treatment of patients with septic shock","volume":"129","author":"Du","year":"2016","journal-title":"Chin. Med. J. Engl."},{"key":"B19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/bja\/aex231","article-title":"Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days","volume":"119","author":"Fuchs","year":"2017","journal-title":"Br. J. Anaesth."},{"key":"B20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s42077-020-00107-5","article-title":"Evaluation of the safety and efficacy of beta blockers in septic patients: A randomized control trial","volume":"12","author":"Gadallah","year":"2020","journal-title":"Ain-Shams J. Anesthesiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10286-018-0528-9","article-title":"Roles of catechol neurochemistry in autonomic function testing","volume":"28","author":"Goldstein","year":"2018","journal-title":"Clin. Auton. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.surg.2005.10.010","article-title":"Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis","volume":"139","author":"Gore","year":"2006","journal-title":"Surgery"},{"key":"B23","first-page":"A16250","article-title":"Evaluation of centhaquine, a novel resuscitative agent hemorrhagic shock patients","volume":"140","author":"Gulati","year":"2019","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/01.ccm.0000649224.29144.8f","article-title":"A phase II multicentric randomized controlled study of centhaquine in hemorrhagic shock patients","volume":"48","author":"Gulati","year":"2020","journal-title":"Crit. Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s40265-021-01547-5","article-title":"A multicentric, randomized, controlled phase III study of centhaquine (Lyfaquin\u00ae) as a resuscitative agent in hypovolemic shock patients","volume":"81","author":"Gulati","year":"2021","journal-title":"Drugs"},{"key":"B76","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/01.ccm.0000550815.69306.46","article-title":"23","volume":"47","author":"Gulati","year":"2019","journal-title":"Crit. Care Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1007\/s12325-021-01760-4","article-title":"Resuscitative effect of centhaquine (Lyfaquin\u00ae) in hypovolemic shock patients: A randomized, multicentric, controlled trial","volume":"38","author":"Gulati","year":"2021","journal-title":"Adv. Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1358\/dof.2020.45.3.3098155","article-title":"Centhaquine citrate. alpha2B-Adrenoceptor ligand, Resuscitative agent for hypovolemic shock","volume":"45","author":"Gulati","year":"2020","journal-title":"Drugs Future"},{"key":"B27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jss.2012.02.005","article-title":"Centhaquin improves resuscitative effect of hypertonic saline in hemorrhaged rats","volume":"178","author":"Gulati","year":"2012","journal-title":"J. Surg. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"A130","DOI":"10.1097\/01.ccm.0000439677.20938.e9","article-title":"534: Resuscitative efficacy of centhaquin in a rabbit model of uncontrolled hemorrhagic shock","volume":"41","author":"Gulati","year":"2013","journal-title":"Crit. Care Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.ccm.0000424804.45748.c1","article-title":"587: Alpha adrenergic receptors mediate resuscitative effect of centhaquin in hemorrhaged rats","volume":"40","author":"Gulati","year":"2012","journal-title":"Crit. Care Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.ajem.2013.05.032","article-title":"Efficacy of centhaquin as a small volume resuscitative agent in severely hemorrhaged rats","volume":"31","author":"Gulati","year":"2013","journal-title":"Am. J. Emerg. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s13054-018-2265-9","article-title":"Prevalence and risk factors for acute kidney injury among trauma patients: A multicenter cohort study","volume":"22","author":"Harrois","year":"2018","journal-title":"Crit. Care"},{"key":"B32","volume-title":"Shock","author":"Haseer Koya","year":"2022"},{"key":"B33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/46040","article-title":"Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission","volume":"402","author":"Hein","year":"1999","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1515\/jccm-2016-0018","article-title":"The diagnosis and hemodynamic monitoring of circulatory shock: Current and future trends","volume":"2","author":"Hendy","year":"2016","journal-title":"J. Crit. Care Med. (Targu Mures)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00068-018-0980-1","article-title":"Resuscitation with centhaquin and 6% hydroxyethyl starch 130\/0.4 improves survival in a swine model of hemorrhagic shock: A randomized experimental study","volume":"45","author":"Kontouli","year":"2019","journal-title":"Eur. J. Trauma Emerg. Surg."},{"key":"B36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/bph.12248","article-title":"A structural chemogenomics analysis of aminergic GPCRs: Lessons for histamine receptor ligand design","volume":"170","author":"Kooistra","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B37","first-page":"337","article-title":"Presynaptic regulation of the release of catecholamines","volume":"32","author":"Langer","year":"1980","journal-title":"Pharmacol. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jss.2012.08.042","article-title":"Resuscitative effect of centhaquin after hemorrhagic shock in rats","volume":"179","author":"Lavhale","year":"2013","journal-title":"J. Surg. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3389\/fimmu.2018.00838","article-title":"Endothelial activation: The ang\/tie Axis in sepsis","volume":"9","author":"Leligdowicz","year":"2018","journal-title":"Front. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejphar.2016.07.016","article-title":"Centhaquin attenuates hyperalgesia and non-evoked guarding in a rat model of postoperative pain primarily through \u03b12B-adrenoceptors","volume":"789","author":"Leonard","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1126\/science.273.5276.803","article-title":"Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c","volume":"273","author":"Link","year":"1996","journal-title":"Science"},{"key":"B42","first-page":"48","article-title":"Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog","volume":"48","author":"Link","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1124\/pr.114.009944","article-title":"What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?","volume":"67","author":"Michino","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"key":"B45","first-page":"353","article-title":"An appraisal of selection and use of catecholamines in septic shock - old becomes new again","volume":"8","author":"Myburgh","year":"2006","journal-title":"Crit. Care Resusc."},{"key":"B46","first-page":"352","article-title":"Catecholamines for shock: The quest for high-quality evidence","volume":"9","author":"Myburgh","year":"2007","journal-title":"Crit. Care Resusc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/jphp.12498","article-title":"Pharmacokinetics of centhaquin citrate in a rat model","volume":"68","author":"O'Donnell","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/jphp.12554","article-title":"Pharmacokinetics of centhaquin citrate in a dog model","volume":"68","author":"O'Donnell","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jss.2015.06.056","article-title":"Centhaquin improves survival in a swine model of hemorrhagic shock","volume":"200","author":"Papapanagiotou","year":"2016","journal-title":"J. Surg. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0304-4165(82)90122-2","article-title":"Catecholamine binding to the alpha-adrenergic receptors of hamster adipocytes. Evidence that guanine nucleotides regulate this binding to the alpha 2-receptor subtype","volume":"714","author":"Pecquery","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.3390\/ijms22115783","article-title":"Targeting adrenergic receptors in metabolic therapies for heart failure","volume":"22","author":"Perez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"R287","DOI":"10.1152\/ajpregu.00123.2002","article-title":"Physiological significance of alpha(2)-adrenergic receptor subtype diversity: One receptor is not enough","volume":"283","author":"Philipp","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.celrep.2019.10.088","article-title":"Structural basis of the diversity of adrenergic receptors","volume":"29","author":"Qu","year":"2019","journal-title":"Cell Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/01.ccm.0000645620.40050.9f","article-title":"Centhaquine upregulates hif1-a and protects hemorrhage-induced acute kidney injury","volume":"48","author":"Ranjan","year":"2020","journal-title":"Crit. Care Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"616253","DOI":"10.3389\/fphar.2021.616253","article-title":"Centhaquine restores renal blood flow and protects tissue damage after hemorrhagic shock and renal ischemia","volume":"12","author":"Ranjan","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/01.hyp.15.2.119","article-title":"Adrenergic receptors. Models for regulation of signal transduction processes","volume":"15","author":"Raymond","year":"1990","journal-title":"Hypertension"},{"key":"B57","doi-asserted-by":"publisher","first-page":"6E","DOI":"10.1016\/0002-9149(86)90716-2","article-title":"Alpha-adrenergic receptors and blood pressure control","volume":"57","author":"Reid","year":"1986","journal-title":"Am. J. Cardiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1055\/s-0034-1375629","article-title":"Synthesis and characterization of centhaquin and its citrate salt and a comparative evaluation of their cardiovascular actions","volume":"65","author":"Reniguntala","year":"2015","journal-title":"Drug Res. (Stuttg)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cvex.2016.01.010","article-title":"Basic shock physiology and critical Care","volume":"19","author":"Roberts","year":"2016","journal-title":"Vet. Clin. North Am. Exot. Anim. Pract."},{"key":"B60","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1186\/cc6976","article-title":"Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression","volume":"12","author":"Schmittinger","year":"2008","journal-title":"Crit. Care"},{"key":"B61","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1442-2042.2007.01956.x","article-title":"Alpha1-adrenoceptor subtypes and lower urinary tract symptoms","volume":"15","author":"Schwinn","year":"2008","journal-title":"Int. J. Urol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1038034","DOI":"10.1155\/2016\/1038034","article-title":"The effect of esmolol on tissue perfusion and clinical prognosis of patients with severe sepsis: A prospective cohort study","volume":"2016","author":"Shang","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"B63","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/00005373-200209000-00022","article-title":"Decompensation characterized by decreased perfusion of the heart and brain during hemorrhagic shock: Role of endothelin-1","volume":"53","author":"Sharma","year":"2002","journal-title":"J. Trauma"},{"key":"B64","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13054-019-2347-3","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: Fifth edition","volume":"23","author":"Spahn","year":"2019","journal-title":"Crit. Care"},{"key":"B65","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3238\/arztebl.2018.0757","article-title":"The nomenclature, definition and distinction of types of shock","volume":"115","author":"Standl","year":"2018","journal-title":"Dtsch. Arztebl Int."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/pro.5560020802","article-title":"Structure, function, and regulation of adrenergic receptors","volume":"2","author":"Strosberg","year":"1993","journal-title":"Protein Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s002109900093","article-title":"Occurrence, pharmacology and function of presynaptic alpha2-autoreceptors in alpha2A\/D-adrenoceptor-deficient mice","volume":"360","author":"Trendelenburg","year":"1999","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/pl00005111","article-title":"A re-investigation of questionable subclassifications of presynaptic alpha2-autoreceptors: Rat vena cava, rat atria, human kidney and Guinea-pig urethra","volume":"356","author":"Trendelenburg","year":"1997","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e011991","DOI":"10.1161\/JAHA.119.011991","article-title":"Cardiogenic shock","volume":"8","author":"Vahdatpour","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/nejmra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1016\/j.jemermed.2015.06.033","article-title":"Prompt diagnosis of an unusual cause of obstructive shock using point-of-care ultrasound","volume":"49","author":"Wilson","year":"2015","journal-title":"J. Emerg. Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/biom11070936","article-title":"Ligands of adrenergic receptors: A structural point of view","volume":"11","author":"Wu","year":"2021","journal-title":"Biomolecules"},{"key":"B73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-020-00435-w","article-title":"G protein-coupled receptors: Structure- and function-based drug discovery","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"60","DOI":"10.21037\/jeccm.2019.10.05","article-title":"Association and dissociation of microcirculation and macrocirculation in critically ill patients with shock","volume":"3","author":"Yeh","year":"2019","journal-title":"J. Emerg. Crit. Care Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"H1377","DOI":"10.1152\/ajpheart.00504.2009","article-title":"Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction","volume":"297","author":"Yoo","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1094591\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T05:48:08Z","timestamp":1673848088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1094591\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":77,"alternative-id":["10.3389\/fphys.2023.1094591"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2023.1094591","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"article-number":"1094591"}}